IndraLab

Statements

Rosuvastatin inhibits NLRP3. 3 / 3
| 3
reach
"Furthermore, rosuvastatin significantly inhibited the activation of NLRP3 inflammasome in this animal model."
29568858
reach
"Both ticagrelor and rosuvastatin reduced postinfarction activation of NLRP3 inflammasome [136]."
34123416
reach
"Furthermore, spironolactone and rosuvastatin, the two-hit anti-inflammatory agents, reduced NLR family pyrin domain containing 3 (NLRP3)/GSDMD pyroptosis in EAT and autophagy in myocardium of HFpEF mouse."
36356543